vs

Side-by-side financial comparison of FIRST CAPITAL INC (FCAP) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.

Pulmonx Corp is the larger business by last-quarter revenue ($20.6M vs $13.5M, roughly 1.5× FIRST CAPITAL INC). FIRST CAPITAL INC runs the higher net margin — 36.2% vs -66.3%, a 102.5% gap on every dollar of revenue. On growth, FIRST CAPITAL INC posted the faster year-over-year revenue change (19.0% vs -8.7%). Over the past eight quarters, FIRST CAPITAL INC's revenue compounded faster (13.4% CAGR vs -0.5%).

Capital First Ltd, formerly known as Future Capital Holdings, was an Indian non-bank financial institution which provided debt financing. In December 2018, it was merged into IDFC Bank to form IDFC First Bank. The company was listed on the NSE and BSE prior to the merger.

Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.

FCAP vs LUNG — Head-to-Head

Bigger by revenue
LUNG
LUNG
1.5× larger
LUNG
$20.6M
$13.5M
FCAP
Growing faster (revenue YoY)
FCAP
FCAP
+27.6% gap
FCAP
19.0%
-8.7%
LUNG
Higher net margin
FCAP
FCAP
102.5% more per $
FCAP
36.2%
-66.3%
LUNG
Faster 2-yr revenue CAGR
FCAP
FCAP
Annualised
FCAP
13.4%
-0.5%
LUNG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FCAP
FCAP
LUNG
LUNG
Revenue
$13.5M
$20.6M
Net Profit
$4.9M
$-13.7M
Gross Margin
77.9%
Operating Margin
-40.9%
Net Margin
36.2%
-66.3%
Revenue YoY
19.0%
-8.7%
Net Profit YoY
49.6%
5.5%
EPS (diluted)
$1.45
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCAP
FCAP
LUNG
LUNG
Q1 26
$20.6M
Q4 25
$13.5M
$22.6M
Q3 25
$13.3M
$21.5M
Q2 25
$12.4M
$23.9M
Q1 25
$11.4M
$22.5M
Q4 24
$11.3M
$23.8M
Q3 24
$10.9M
$20.4M
Q2 24
$10.7M
$20.8M
Net Profit
FCAP
FCAP
LUNG
LUNG
Q1 26
$-13.7M
Q4 25
$4.9M
$-10.4M
Q3 25
$4.5M
$-14.0M
Q2 25
$3.8M
$-15.2M
Q1 25
$3.2M
$-14.4M
Q4 24
$3.3M
$-13.2M
Q3 24
$2.9M
$-14.1M
Q2 24
$2.8M
$-15.3M
Gross Margin
FCAP
FCAP
LUNG
LUNG
Q1 26
77.9%
Q4 25
77.6%
Q3 25
74.7%
Q2 25
72.1%
Q1 25
72.5%
Q4 24
74.0%
Q3 24
73.7%
Q2 24
73.7%
Operating Margin
FCAP
FCAP
LUNG
LUNG
Q1 26
-40.9%
Q4 25
-43.8%
Q3 25
41.8%
-66.9%
Q2 25
37.2%
-62.0%
Q1 25
34.2%
-64.6%
Q4 24
34.8%
-56.5%
Q3 24
31.5%
-69.3%
Q2 24
31.1%
-75.2%
Net Margin
FCAP
FCAP
LUNG
LUNG
Q1 26
-66.3%
Q4 25
36.2%
-46.1%
Q3 25
33.8%
-64.9%
Q2 25
30.4%
-63.6%
Q1 25
28.3%
-64.1%
Q4 24
28.8%
-55.4%
Q3 24
26.5%
-69.4%
Q2 24
26.5%
-73.7%
EPS (diluted)
FCAP
FCAP
LUNG
LUNG
Q1 26
$-0.33
Q4 25
$1.45
$-0.25
Q3 25
$1.34
$-0.34
Q2 25
$1.13
$-0.38
Q1 25
$0.97
$-0.36
Q4 24
$0.97
$-0.33
Q3 24
$0.87
$-0.36
Q2 24
$0.85
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCAP
FCAP
LUNG
LUNG
Cash + ST InvestmentsLiquidity on hand
$61.6M
Total DebtLower is stronger
$37.3M
Stockholders' EquityBook value
$137.8M
$45.8M
Total Assets
$1.3B
$120.0M
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCAP
FCAP
LUNG
LUNG
Q1 26
$61.6M
Q4 25
$69.8M
Q3 25
$76.5M
Q2 25
$75.5M
Q1 25
$74.6M
Q4 24
$70.9M
Q3 24
$63.3M
Q2 24
$63.5M
Total Debt
FCAP
FCAP
LUNG
LUNG
Q1 26
$37.3M
Q4 25
$37.1M
Q3 25
$37.1M
Q2 25
$37.1M
Q1 25
$37.2M
Q4 24
$37.2M
Q3 24
$37.2M
Q2 24
$37.2M
Stockholders' Equity
FCAP
FCAP
LUNG
LUNG
Q1 26
$45.8M
Q4 25
$137.8M
$54.1M
Q3 25
$132.4M
$60.0M
Q2 25
$123.2M
$69.1M
Q1 25
$120.1M
$77.7M
Q4 24
$114.6M
$85.8M
Q3 24
$116.8M
$93.9M
Q2 24
$107.8M
$101.2M
Total Assets
FCAP
FCAP
LUNG
LUNG
Q1 26
$120.0M
Q4 25
$1.3B
$129.3M
Q3 25
$1.2B
$138.3M
Q2 25
$1.2B
$147.2M
Q1 25
$1.2B
$150.7M
Q4 24
$1.2B
$162.8M
Q3 24
$1.2B
$167.4M
Q2 24
$1.2B
$172.6M
Debt / Equity
FCAP
FCAP
LUNG
LUNG
Q1 26
0.82×
Q4 25
0.69×
Q3 25
0.62×
Q2 25
0.54×
Q1 25
0.48×
Q4 24
0.43×
Q3 24
0.40×
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCAP
FCAP
LUNG
LUNG
Operating Cash FlowLast quarter
$21.3M
Free Cash FlowOCF − Capex
$19.9M
FCF MarginFCF / Revenue
147.7%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
4.36×
TTM Free Cash FlowTrailing 4 quarters
$35.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCAP
FCAP
LUNG
LUNG
Q1 26
Q4 25
$21.3M
$-7.1M
Q3 25
$7.9M
$-8.2M
Q2 25
$3.7M
$-3.9M
Q1 25
$4.4M
$-13.2M
Q4 24
$22.3M
$-6.7M
Q3 24
$7.6M
$-7.2M
Q2 24
$3.5M
$-5.8M
Free Cash Flow
FCAP
FCAP
LUNG
LUNG
Q1 26
Q4 25
$19.9M
$-7.1M
Q3 25
$7.8M
$-8.3M
Q2 25
$3.5M
$-4.0M
Q1 25
$4.2M
$-13.5M
Q4 24
$21.6M
$-6.8M
Q3 24
$7.5M
$-7.7M
Q2 24
$3.3M
$-6.2M
FCF Margin
FCAP
FCAP
LUNG
LUNG
Q1 26
Q4 25
147.7%
-31.4%
Q3 25
58.6%
-38.4%
Q2 25
27.8%
-16.6%
Q1 25
36.5%
-60.0%
Q4 24
190.7%
-28.8%
Q3 24
68.6%
-37.6%
Q2 24
31.2%
-30.0%
Capex Intensity
FCAP
FCAP
LUNG
LUNG
Q1 26
Q4 25
10.0%
0.1%
Q3 25
1.2%
0.4%
Q2 25
2.2%
0.2%
Q1 25
1.9%
1.3%
Q4 24
6.3%
0.5%
Q3 24
0.8%
2.0%
Q2 24
1.4%
2.3%
Cash Conversion
FCAP
FCAP
LUNG
LUNG
Q1 26
Q4 25
4.36×
Q3 25
1.77×
Q2 25
0.99×
Q1 25
1.36×
Q4 24
6.84×
Q3 24
2.62×
Q2 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons